Home › Funds › Simplify Asset Management Inc. › ARQT

Simplify Asset Management Inc. position in ARQT

ARCUTIS BIOTHERAPEUTICS INC · Health Care

Simplify Asset Management Inc. reported holding 865,862 shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$22.9M, representing 0.38% of its reported portfolio and ranking #13 among its reported holdings. Simplify Asset Management Inc. has disclosed ARQT holdings in 5 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)865.86K sh
Reported value held$22.88M
Portfolio Weight0.38%
First reportedQ4 2024
Last changeNew
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Simplify Asset Management Inc.'s ARQT position evolved

Simplify Asset Management Inc. first disclosed a stake in ARQT in Q4 2024 at 742,299 shares (US$10.3M). The position peaked in Q3 2026 at 865,862 shares, worth US$22.9M. Across 5 filings, Simplify Asset Management Inc. increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 865,862 shares valued at US$22.9M. Notable position changes include a 38% trim in Q2 2025 (shares rose 34% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 742.30K $10.34M New
Q1 2025 660.56K $10.33M Reduce
Q2 2025 409.43K $5.74M Reduce
Q3 2025 318.00K $5.99M Reduce
Q3 2026 865.86K $22.88M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ARQT and 13F data

ARQT (ARCUTIS BIOTHERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in ARQT — the largest reported positions include MONTANOVA CAPITAL, LLC (US$326.1M), Frazier Life Sciences Management, L.P. (US$258.9M), Rubric Capital Management LP (US$216.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ARQT

All ARQT fund holders →

FAQ

How long has Simplify Asset Management Inc. held ARQT?

Simplify Asset Management Inc. has disclosed ARQT holdings in 5 of the last 8 reported quarters, going back to Q4 2024.

What is Simplify Asset Management Inc.'s current position in ARQT?

As of Q3 2026, Simplify Asset Management Inc. holds 865.86K shares of ARQT (ARCUTIS BIOTHERAPEUTICS INC), valued at $22.88M, representing 0.38% of its reported portfolio and ranking #13.

Has Simplify Asset Management Inc. been buying or selling ARQT?

In the latest 13F filing (Q3 2026), Simplify Asset Management Inc. newly opened its position in ARQT. The position peaked in Q3 2026 at 865.86K shares.

Which other funds hold ARQT?

Other major institutional holders of ARQT include MONTANOVA CAPITAL, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.